Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Miahelsa HoldingsTSE:7129 +0.70%45 5-Year Yield-on-Cost % is 2.61 as of Aug. 02, 2026, which is 3% below its 10-year median of 2.70. GuruFocus rates TSE:7129 with a GF Score™ of 45/100 and a GF Value™ of 円1,071.00 (Fairly Valued). The stock has 3 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Miahelsa Holdings ranks worse than 54.91% on this metric.
Miahelsa Holdings's yield on cost for the quarter that ended in Mar. 2026 was 2.61.
The historical rank and industry rank for Miahelsa Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:7129'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.48 Med: 2.7 Max: 3.03
Current: 2.61
During the past 5 years, Miahelsa Holdings's highest Yield on Cost was 3.03. The lowest was 1.48. And the median was 2.70.
TSE:7129's 5-Year Yield-on-Cost % is ranked worse than 54.91% of 275
companies
in the Healthcare Providers & Services industry
Industry Median: 2.93
vs TSE:7129: 2.61
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Miahelsa Holdings 5-Year Yield-on-Cost % Related Terms
For the Pharmaceutical Retailers subindustry, Miahelsa Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Miahelsa Holdings 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Miahelsa Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Miahelsa Holdings's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Miahelsa Holdings (TSE:7129) has a 5-Year Yield-on-Cost % of 2.61 as of Aug. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Miahelsa Holdings and its competitors. This is near median its historical median of 2.70. Over the past decade, Miahelsa Holdings' 5-Year Yield-on-Cost % has ranged from 1.48 to 3.03. According to the industry distribution chart, Miahelsa Holdings ranks #151 out of 275 companies in the Healthcare Providers & Services industry, placing it in the top 54.9%.
Is Miahelsa Holdings' 5-Year Yield-on-Cost % too high?
Miahelsa Holdings' current 5-Year Yield-on-Cost % of 2.61 is near median its 10-year median of 2.70. Over the past 10 years, this metric has ranged from a low of 1.48 to a high of 3.03. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.93. Miahelsa Holdings' value of 2.61 is 10.9% below this industry median. Based on the distribution chart, Miahelsa Holdings ranks #151 out of 275 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Miahelsa Holdings has a GF Score™ of 45/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Miahelsa Holdings' 5-Year Yield-on-Cost % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Miahelsa Holdings ranks #151 out of 275 companies for 5-Year Yield-on-Cost %. This places Miahelsa Holdings in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.93. Miahelsa Holdings' value of 2.61 is 10.9% below this benchmark. Historically, Miahelsa Holdings' own 5-Year Yield-on-Cost % has ranged from 1.48 to 3.03 over the past decade. While the company's 10-year median is 2.70 vs. the industry median of 2.93, Miahelsa Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.93, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Miahelsa Holdings's current 5-Year Yield-on-Cost % of 2.61 is 10.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Miahelsa Holdings and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.93 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Miahelsa Holdings's current 5-Year Yield-on-Cost % is 2.61, which is near median its own 10-year median of 2.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Miahelsa Holdings stock overvalued right now?
Based on GuruFocus' analysis, Miahelsa Holdings (TSE:7129) is currently considered Fairly Valued. The stock's GF Value™ is 円1,071.00, compared to a current price of 円1,158.00 — trading 8.1% above its estimated fair value. The current 5-Year Yield-on-Cost % is 2.61, which is near median its 10-year median of 2.70 and 10.9% below the Healthcare Providers & Services industry median of 2.93. Miahelsa Holdings' overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Miahelsa Holdings (TSE:7129), the current 5-Year Yield-on-Cost % is 2.61 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Miahelsa Holdings (TSE:7129) Overvalued in 2026?
Based on GuruFocus' analysis, Miahelsa Holdings stock appears to be overvalued.
The current stock price of 円1,158.00 is trading 8.1% above its estimated GF Value™ of 円1,071.00.
GuruFocus considers Miahelsa Holdings to be Fairly Valued.
Key valuation signals for TSE:7129:
5-Year Yield-on-Cost %: 2.61 (near median its 10-year median of 2.70)
GF Value™: 円1,071.00 vs. price of 円1,158.00 (8.1% above fair value)
Industry Position: 10.9% below the Healthcare Providers & Services median (#151 of 275)
No single metric tells the full story. See the TSE:7129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Miahelsa Holdings Corp, along with its subsidiaries, operates in the following reportable segments: Pharmaceutical Business, Nursing Care Business, and Childcare Business. The majority of its revenue is generated from the Pharmaceuticals Business, which operates pharmaceutical dispensaries in Japan through Nissei Pharmacy and Miahelsa Pharmacy brands, and also offers home care services. The Nursing care business mainly provides housing, medical care, nursing care, prevention, and lifestyle support for elderly people, and the Childcare segment involves the operation of licensed childcare centers. In addition, the group also operates a food business providing food suitable for all ages, from infants to the elderly.
45GF Score
Get the complete analysis for TSE:7129
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7129 has been successfully added to your 
